Patient and Physician Factors Associated With Pulmonary Function Testing for COPD A Population Study

被引:46
作者
Gershon, Andrea S. [1 ,2 ,3 ,4 ]
Hwee, Jeremiah [2 ]
Croxford, Ruth [2 ]
Aaron, Shawn D. [5 ]
To, Teresa [2 ,3 ,4 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada
[2] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada
[3] Univ Toronto, Fac Med, Toronto, ON, Canada
[4] Hosp Sick Children SickKids, Toronto, ON, Canada
[5] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada
基金
加拿大健康研究院;
关键词
SPIROMETRY USE; DIAGNOSIS; DISEASE; PREVALENCE; RISK; INDIVIDUALS; MANAGEMENT; ACCURACY; HISTORY;
D O I
10.1378/chest.13-0790
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The diagnosis of COPD is made by objectively demonstrating nonreversible airflow obstruction of the lungs. Despite this, rates of pulmonary function testing (PFT) for diagnosis remain low. It is still not known why testing is underused. Methods: We conducted a population study using the health administrative data of all individuals 35 years of age and older newly diagnosed with COPD in Ontario, Canada, between 2000 and 2010. Receipt of PFT during the peridiagnostic period (between 1 year before and 1 year after a diagnosis of COPD) was determined and related to patient demographic and clinical characteristics as well as primary care physician and health-care system factors. Results: Only 35.9% of the 491,754 Ontarians newly diagnosed with COPD during the study period received PFT. Individuals diagnosed before age 50 years or after age 80 years, those living in long-term care, and those with stroke and/or dementia were less likely to receive testing. Patients who had a medical specialist involved in their care and/or had other coexisting pulmonary disease were more likely to receive testing. Finally, older primary care physicians were less likely to order testing for their patients. Conclusions: Only about one-third of individuals with COPD in Ontario, Canada, received PFT to confirm their diagnosis; age, comorbidity, and physician factors appear to influence its use. Targeted strategies that address these factors could increase the rate of appropriate testing of people with suspected COPD and improve quality of COPD care.
引用
收藏
页码:272 / 281
页数:10
相关论文
共 33 条
  • [1] [Anonymous], 2006, J HOPK U ACG CAS MIX
  • [2] Anthonisen N R, 2005, Can Respir J, V12, P69
  • [3] How often is diagnosis of COPD confirmed with spirometry?
    Arne, Mats
    Lisspers, Karin
    Stallberg, Bjorn
    Boman, Gunnar
    Hedenstrom, Hans
    Janson, Christer
    Emtner, Margareta
    [J]. RESPIRATORY MEDICINE, 2010, 104 (04) : 550 - 556
  • [4] Association between inhaled β-agonists and the risk of unstable angina and myocardial infarction
    Au, DH
    Curtis, JR
    Every, NR
    McDonell, MB
    Fihn, SD
    [J]. CHEST, 2002, 121 (03) : 846 - 851
  • [5] Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research
    Austin, Peter C.
    [J]. COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION, 2009, 38 (06) : 1228 - 1234
  • [6] Barr R Graham, 2005, Am J Med, V118, P1415
  • [7] Benady S., 2010, The human and economic burden of COPD: A leading cause of hospital admission in Canada
  • [8] British Columbia Ministry of Health, 2007, BCPHARMACARE NEWSL
  • [9] International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
    Buist, A. Sonia
    McBurnie, Mary Ann
    Vollmer, William M.
    Gillespie, Suzanne
    Burney, Peter
    Mannino, David M.
    Menezes, Ana M. B.
    Sullivan, Sean D.
    Lee, Todd A.
    Weiss, Kevin B.
    Jensen, Robert L.
    Marks, Guy B.
    Gulsvik, Amund
    Nizankowska-Mogilnicka, Ewa
    [J]. LANCET, 2007, 370 (9589) : 741 - 750
  • [10] Damarla M, 2006, RESP CARE, V51, P1120